Search Results - "Maja, Berkovic Cigrovski"

Refine Results
  1. 1
  2. 2

    Minireview: are SGLT2 inhibitors heart savers in diabetes? by Grubić Rotkvić, Petra, Cigrovski Berković, Maja, Bulj, Nikola, Rotkvić, Luka

    Published in Heart failure reviews (01-11-2020)
    “…Sodium-glucose cotransporter 2 (SGLT2) inhibitors, a class of drugs that promote urinary glucose excretion in the treatment of diabetes, have provoked large…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Flash Glucose Monitoring in Croatia: The Optimal Number of Scans per Day to Achieve Good Glycemic Control in Type 1 Diabetes by Canecki-Varzic, Silvija, Prpic-Krizevac, Ivana, Cigrovski Berkovic, Maja, Rahelic, Dario, Schonberger, Ema, Gradiser, Marina, Bilic-Curcic, Ines

    Published in Medicina (Kaunas, Lithuania) (01-10-2023)
    “…Background and Objectives: The purpose of this study is to determine the optimal number of scans per day required for attaining good glycemic regulation…”
    Get full text
    Journal Article
  5. 5

    Are We Compensating for the Lack of Physical Activity in Our Diabetic Patients with Treatment Intensification? by Maja Cigrovski Berkovic, Maja Cigrovski, Bilic-Curcic, Ines, Gradiser, Marina, Herman-Mahecic, Davorka, Cigrovski, Vjekoslav, Ivandic, Marul

    Published in Sports (Basel) (07-08-2017)
    “…We studied the association between leisure time physical activity (LTPA) and glycemic control, body mass index (BMI), and hypoglycemic incidents in type 1…”
    Get full text
    Journal Article
  6. 6

    Sodium-glucose cotransporter 2 inhibitors’ mechanisms of action in heart failure by Rotkvić, Petra Grubić, Berković, Maja Cigrovski, Bulj, Nikola, Rotkvić, Luka, Ćelap, Ivana

    Published in World journal of diabetes (15-07-2020)
    “…Three major cardiovascular outcome trials (CVOTs) with a new class of antidiabetic drugs - sodium-glucose cotransporter 2 (SGLT2) inhibitors (EMPA-REG OUTCOME…”
    Get full text
    Journal Article
  7. 7

    THE IMPACT OF TOTAL PHYSICAL ACTIVITY ON MICROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS PATIENTS by Turčinović, Katarina, Cigrovski, Vjekoslav, Bilić-Ćurćić, Ines, Mrzljak, Anna, Kuna, Lucija, Klobučar, Sanja, Cigrovski Berković, Maja

    Published in Acta clinica Croatica (Tisak) (01-01-2023)
    “…The incidence of diabetes is increasing worldwide, emphasizing an emerging need for blood glucose control optimization to prevent the development of chronic…”
    Get full text
    Journal Article
  8. 8

    Thyroid Stimulating Hormone as a Possible Additional COVID-19 Outcome Marker by Zrilic Vrkljan, Anamarija, Majic Tengg, Ana, Palaversa, Tanja, Marusic, Srecko, Ruzic, Lana, Bilic-Curcic, Ines, Cigrovski Berkovic, Maja

    Published in Medicina (Kaunas, Lithuania) (01-02-2024)
    “…: The interaction between thyroid and SARS-CoV-2 is complex and not yet fully understood. This study aimed to identify a predictive value of serum TSH levels…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Primary hyperparathyroidism-induced acute pancreatitis in pregnancy: A systematic review with a diagnostic-treatment algorithm by Augustin, Goran, Lai, Quirino, Cigrovski Berkovic, Maja

    Published in World journal of gastroenterology : WJG (28-08-2024)
    “…Primary hyperparathyroidism (PHPT)-induced acute pancreatitis (AP) during pregnancy has rarely been described. Due to this rarity, there are no diagnostic or…”
    Get full text
    Journal Article
  12. 12

    IL-2 −330 T/G SNP and serum values—potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs) by Cigrovski Berković, Maja, Jokić, Mladen, Marout, Jasminka, Radošević, Senka, Zjačić-Rotkvić, Vanja, Kapitanović, Sanja

    “…Cytokines participate in tumorigenesis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Single nucleotide polymorphisms (SNPs) in cytokine genes…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Ocular myasthenia gravis-like symptoms associated with erenumab: Case report by Marusic, Srecko, Andric, Jelena, Cigrovski Berkovic, Maja

    “…We present a case of a patient who developed myasthenia gravis (MG)-like symptoms during erenumab treatment. The patient had a years-long history of chronic…”
    Get full text
    Journal Article
  15. 15

    Metformin and pancreatic neuroendocrine tumors: A systematic review and meta-analysis by Cigrovski Berkovic, Maja, Coppola, Alessandro, Sesa, Vibor, Mrzljak, Anna, Lai, Quirino

    Published in World journal of gastroenterology : WJG (21-02-2024)
    “…Most patients with advanced pancreatic neuroendocrine tumors (pNETs) die due to tumor progression. Therefore, identifying new therapies with low toxicity and…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Male sex hormones response after a month-long Himalayas trek in relation to hemoglobin oxygen saturation by Ružić, Lana, Cigrovski Berković, Maja, Starčević, Hrvoje, Lovrić, Dražen, Matković, Branka R.

    Published in Kinesiology (Zagreb, Croatia) (2018)
    “…High-altitude tourism is becoming increasingly popular among non-athletic population, but its potential impact on health is often neglected. This study…”
    Get full text
    Journal Article Paper
  18. 18

    Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management by Cigrovski Berkovic, Maja, Virovic-Jukic, Lucija, Bilic-Curcic, Ines, Mrzljak, Anna

    Published in World journal of gastroenterology : WJG (07-06-2020)
    “…Liver cirrhosis and diabetes mellitus (DM) are both common conditions with significant socioeconomic burden and impact on morbidity and mortality. A…”
    Get full text
    Journal Article
  19. 19

    Managing end-stage carcinoid heart disease: A case report and literature review by Bulj, Nikola, Tomasic, Vedran, Cigrovski Berkovic, Maja

    Published in World journal of gastrointestinal oncology (15-03-2024)
    “…Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) are rare tumors, often diagnosed in an advanced stage when curative treatment is impossible and…”
    Get full text
    Journal Article
  20. 20

    Semaglutide-eye-catching results by Cigrovski Berkovic, Maja, Strollo, Felice

    Published in World journal of diabetes (15-04-2023)
    “…Semaglutide is a glucagon-like peptide-1 receptor agonist used either orally every day or subcutaneously once a week for the treatment of type 2 diabetes…”
    Get full text
    Journal Article